Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 3 registrations
Spain
AEMPS · 3 registrations
- Emblaveo 1,5 G/0,5 G Polvo Para Concentrado Para Solucion Para Perfusion542 mg + 1500 mg · polvo para concentrado para solución para perfusión · Pfizer Europe Ma Eeig
- Zavicefta 2 G/0,5 G Polvo Para Concentrado Para Solucion Para Perfusion2329,7 mg + 543,5 mg · polvo para concentrado para solución para perfusión · Pfizer Ireland Pharmaceuticals
- Zavicefta 2 G/0,5 G Polvo Para Concentrado Para Solucion Para Perfusion2329,7 mg + 543,5 mg · polvo para concentrado para solución para perfusión · Pfizer Ireland Pharmaceuticals Unlimited Company
European Union
EMA · 2 registrations
Netherlands
CBG-MEB · 2 registrations
At a glance
- Registers
- 9
- Historical lists
- 2
- Registrations
- 19
- With their own page
- 16
- Companies
- 11
All medicines with Avibactam
Human medicines from every register that match Avibactam by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
19 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| AvycazCombination | United States | 0.5GM BASE; 2GM/VIAL | powder | Marketed | Abbvie |
| EmblaveoCombination | United States | 0.5GM BASE/VIAL; 1.5GM/VIAL | powder | Marketed | Abbvie |
| ZaviceftaCombination | European Union | Authorised | Pfizer Ireland Pharmaceuticals Unlimited Company | ||
| Zavicefta 2 G/0,5 G Polvo Para Concentrado Para Solucion Para PerfusionCombination | Spain | 2329,7 mg + 543,5 mg | polvo para concentrado para solución para perfusión | Marketed | Pfizer Ireland Pharmaceuticals |
| Zavicefta 2 G/0,5 G Polvo Para Concentrado Para Solucion Para PerfusionCombination | Spain | 2329,7 mg + 543,5 mg | polvo para concentrado para solución para perfusión | Marketed | Pfizer Ireland Pharmaceuticals Unlimited Company |
| EmblaveoCombination | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Emblaveo 1,5 G/0,5 G Polvo Para Concentrado Para Solucion Para PerfusionCombination | Spain | 542 mg + 1500 mg | polvo para concentrado para solución para perfusión | Marketed | Pfizer Europe Ma Eeig |
| ZAVICEFTA 2 g/0,5 g, poeder voor concentraat voor oplossing voor infusieCombination | Netherlands | Poeder voor concentraat voor oplossing voor infusie | Authorised | Pfizer Ireland Pharmaceuticals, Operations Services Group | |
| Emblaveo 1,5 g/0,5 g poeder voor concentraat voor oplossing voor infusieCombination | Netherlands | Poeder voor concentraat voor oplossing voor infusie | Authorised | Pfizer Europe MA EEIG | |
| Zavicefta®Combination | Serbia | 2g+0.5g | prašak za koncentrat za rastvor za infuziju | Authorised | Pfizer SRB D.O.O. |
| Zavicefta Powder for Concentrate for Solution for Infusion 2G/0.5GCombination | Singapore | 500mg + 2g | injection, powder, for solution | Authorised | Pfizer Private Limited |
| Emblaveo Powder for Concentrate for Solution for Infusion 1.5G/0.5GCombination | Singapore | 0.5 g/vial + 1.5 g/vial | injection, powder, for solution | Authorised | Pfizer Private Limited |
| RyambicCombination | Brazil | Authorised | Pfizer Brasil Ltda | ||
| TorgenaCombination | Brazil | Authorised | Pfizer Brasil Ltda | ||
| ZaviceftaCombination | New Zealand | Inj ceftazidime 2,000 mg with avibactam 500 mg, vial | Funded | ||
| EmblaveoCombination | Croatia | Marketed | |||
| ZAVICEFTA 2 g/0.5 g VialCombination | Saudi Arabia | Authorised | Acs Dobfar SPA | ||
| Ceftazidima Pentaidratada + Avibactam SodicoCombination | Brazil | Cancelled | Pfizer Brasil Ltda | ||
| ZAVICEFTA 2 g/0,5 gCombination | Romania | 2g/0,5g | pulb. pt. conc. pt. sol. perf. | Status unknown | Pfizer Ireland Pharmaceuticals |